JWS
FLGT icon

Juncture Wealth Strategies’s Fulgent Genetics FLGT Stock Holding History

Juncture Wealth Strategies’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,542
Closed -$466K – 108
2022
Q2 		$466K Sell
8,542
-1,898
-18% -$104K 0.23% 70
2022
Q1 		$652K Sell
10,440
-335
-3% -$22.1K 0.31% 63
2021
Q4 		$1.08M Buy
10,775
+926
+9% +$81.4K 0.52% 45
2021
Q3 		$886K Buy
9,849
+1,256
+15% +$114K 0.47% 45
2021
Q2 		$836K Buy
8,593
+3,402
+66% +$272K 0.48% 50
2021
Q1 		$479K Sell
5,191
-5,076
-49% -$524K 0.3% 73
2020
Q4 		$535K Sell
10,267
-940
-8% -$39.3K 0.34% 66
2020
Q3 		$449K Buy
11,207
+1,032
+10% +$32.3K 0.31% 74
2020
Q2 		$163K Buy
+10,175
New +$156K 0.12% 99

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Juncture Wealth Strategies's FLGT Position: Q3 2022 in Review

Juncture Wealth Strategies sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 8,542 shares — an estimated $466K sold.

Juncture Wealth Strategies first reported a position in FLGT in Q2 2020 and held it in 9 quarters. The position peaked at $1.08M in Q4 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Juncture Wealth Strategies reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Juncture Wealth Strategies sold 8,542 Fulgent Genetics shares in Q3 2022, an estimated $466K.
  • Juncture Wealth Strategies first reported a position in Fulgent Genetics in Q2 2020 and held it in 9 quarters.
  • Juncture Wealth Strategies's Fulgent Genetics position peaked at $1.08M in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Juncture Wealth Strategies's 13F filing for Q3 2022, filed 11 Oct 2022.